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CBACKGROUND Despite technical advancements, implantation of
coronary sinus (CS) leads may be challenging, and dislocation
remains a relevant clinical problem.
OBJECTIVE The aim of this study was to investigate the effec-
tiveness, safety, and long-term outcome of stent implantation to
anchor the lead to the wall of the CS side branch.
METHODS Stenting of a CS side branch was performed in 312
patients. The procedure was performed because of postoperative
lead dislocation in 16 patients and because of an intraoperative
unstable lead position or phrenic nerve stimulation in 296 cases.
A bare metal coronary stent was introduced over a second guide
wire in the same CS sheath. The stent was deposited 5–35 mm
proximal to the most proximal electrode. Mechanical damage of
the CS side branch or pericardial effusion was not observed owing
to stenting.
RESULTS During follow-up (median 28.4, interquartile range 15–
37, maximum 70 months), a clinically important increase in theJanuary 6, 2011.)
1547-5271/$ -see front matter © 2011 Published by Elsevier Inc. on behalf of Heoperation was necessary in only two patients (0.6%). Phrenic
erve stimulation was observed in 18 instances, and repositioning
ith an ablation catheter was performed in seven cases. Imped-
nce measurements did not suggest lead insulation failure. Three
tented leads were extracted without complication after 3–49
onths owing to infection, while four leads were extracted easily
uring heart transplantation after 7–27 months.
ONCLUSION Stent implantation to stabilize CS lead position
eems to be an effective and safe procedure in prevention and
reatment of CS lead dislocation in selected cases.
EYWORDS Cardiac resynchronization; LV lead implantation; Cor-
nary sinus; Lead dislocation; Stent implantation
BBREVIATIONS CRT  cardiac resynchronization therapy;
S  coronary sinus; INR  international normalized ratio;
LV  left ventricle; NYHA  New York Heart Association;
PNS  phrenic nerve stimulation
(Heart Rhythm 2011;8:845–850) © 2011 Published by Elsevier Inc.
left ventricular pacing threshold was found in four cases and on behalf of Heart Rhythm Society.Introduction
Cardiac resynchronization therapy (CRT) plays an impor-
tant role in the treatment of severe heart failure in patients
with wide QRS complex and mechanical dyssynchrony.
Despite continuous technical developments in the last few
years, implantation of a CRT system may be challenging.
The success rate of coronary sinus (CS) lead positioning is
88%–96% in previous clinical studies,1–4 but even in the
ecently published MADIT CRT trial, 7.5% of the CS lead
mplantations were unsuccessful.5 During follow-up, 5%–
10% of patients require reoperation because of CS lead
dysfunction.2,3,5–7
Stent implantation, which anchors the CS electrode to the
wall of the CS side branch, may increase the stability of the
This study was supported by the National Development Agency of
Hungary (TÁMOP-4.2.2-08/1/KMR-2008-0004) and an NKTH-OTKA
K68792 grant. Address reprint requests and correspondence: Professor
Béla Merkely, M.D., Ph.D., D.Sc., Heart Center, Semmelweis University,
Városmajor Strasse 68, H-1122 Budapest, Hungary. E-mail address:
merkely.bela@kardio.sote.hu. (Received September 14, 2010; acceptedlead position. A more stable lead position may increase
implantation success rates and decrease the number of post-
operative complications. The procedure of CS lead stenting
was described elsewhere in detail.8–11 In this study, long-
term follow-up results of CS stenting are reported in a larger
patient population.
Methods
CS sinus stenting has been performed since August of 2004
in selected patients after receiving informed consent. The
consent form and the protocol were approved by the Hun-
garian Scientific and Research Ethics Committee of the
Medical Research Council. Data were collected in consec-
utive patients who underwent CS lead stabilization with
stenting in the Heart Center of the Semmelweis University,
Budapest.
CS side branch stenting was performed in 312 patients
with wide QRS (120 ms). New York Heart Association
(NYHA) functional stage was mainly III–IV despite optimal
medical therapy, while 12 patients were in NYHA II stage
at implantation, but their preceding clinical status made this
treatment reasonable (Table 1). At our institute, 784 CRT
eart Rhythm Society. doi:10.1016/j.hrthm.2011.01.016
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846 Heart Rhythm, Vol 8, No 6, June 2011systems were implanted between August 2004 and Septem-
ber 2009, and stenting was applied in 39.7% of CRT pa-
tients. Stent fixation of the CS lead was indicated in cases of
postoperative dislocation (n  16). Furthermore, stenting
was applied when intraoperative macroscopic or micro-
scopic dislocation occurred or phrenic nerve stimulation
(PNS) was observed in a stable anatomical position and the
lead needed to be fixed in a more proximal position (n 
296) (Figure 1).
CS side branch stenting was executed as described else-
where.9 Briefly, after cannulation of the CS ostium with the
Table 1 Baseline Characteristics
Mean age 65.4
Sex:
Male 236
Female 76
NYHA class at implantation:
II 12
III 247
IV 53
Left ventricular ejection fraction (%, median) 28 (23–34)
Medication (% of patients):
Aspirin 36
Clopidogrel or ticlopidine 24
Coumarin 48
Aspirin  coumarin 14
Clopidogrel  coumarin 7
Aspirinclopidogrel 12
Spironolactone 54
Other diuretics 71
Beta-blocker 87
Angiotensin-converting enzyme inhibitors
or angiotensin receptor blockers
84
Figure 1 Coronary venogram. Arrow 1: stable, distal wedge position,
where PNS was observed. Arrow 2: proximal position with ideal pacing
parameters. Intraoperative dislocation was experienced.cout Pro 8F (Biotronik GmbH&Co, Berlin, Germany; in-
er diameter 8 Fr) or Attain LDS 6216A MB2 (Medtronic
nc., Minneapolis, MN; inner diameter 7 Fr) CS sheaths, CS
enography was performed using an occlusion balloon.
enerally, over-the-wire left ventricular (LV) unipolar pas-
ive fixation electrodes were applied: Attain OTW 4193-78
Medtronic; n  186), Corox OTW 75 UP/Steroid (Biotro-
nik; n  118), and Quicksite 1056K-86 (St. Jude, Sylmar,
CA; n 1). Seven patients received bipolar passive fixation
leads (Corox OTW 75 BP/Steroid, Biotronik). After posi-
tioning of the lead, signal amplitude, pacing threshold, and
pacing impedance were measured. PNS was assessed in all
cases. Repositioning of the LV lead was performed if PNS
was apparent during 10 V at 0.5 ms pacing. In case the
physician performing the implantation decided to use stent
implantation, a second guide wire was introduced into the
target vein over the same CS sheath. Over this second guide
wire, a short (mainly 8–15 mm) bare metal coronary stent
was positioned into the CS side branch. The distance be-
tween the pacing tip (or ring) of the lead and the distal end
of the stent was 5–35 mm. The diameter of the stents
(2.25–4 mm, mainly 3 or 3.5 mm) was chosen according to
the diameter of the target CS side branch, which was mea-
sured on the CS venogram. The applied bare metal stents
were as follows: Trimaxx (Abott Vascular, Redwood City,
CA; n  142), Driver (Medtronic, n  57), MicroDriver
(Medtronic, n  21), S670 (Medtronic, n  6), Lekton
Motion (Biotronik, n 35), ProKinetic (Biotronik, n 29),
Liberte (Boston Scientific, Maple Grove, MN, n  19), and
Tsunami Gold (Terumo, Tokyo, Japan, n  3). After measuring
the control pacing threshold and testing the PNS, the stent was
deployed with a pressure of 6–14 atmospheres (Figure 2). The
Figure 2 Coronary stent implantation. S: inflation of the stent; GW:
guide wire of the stent; T: tip of the lead in the final position.duration of balloon inflation was 4–6 seconds.
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847Gellér et al Long-Term Experience with Left Ventricular Lead StentingA biventricular pacemaker was implanted in 207 pa-
tients, while a biventricular defibrillator was indicated in
105 cases. The decision to use a CRT-P or a CRT-D im-
plantation was at the discretion of the operator. In patients
with permanent atrial fibrillation (n  99), only right ven-
tricular and CS leads were implanted.
Additional antiplatelet or anticoagulant therapy was not
used after CS side branch stenting; only the preprocedural
anticoagulant and/or antiplatelet treatment was continued
(Table 1). The antithrombotic treatment was chosen accord-
ing to current guidelines. The mean daily dosages were the
following: aspirin 100 mg, clopidogrel 75 mg, and ticlopi-
dine 2  250 mg. The international normalized ratio (INR)
arget value was 2–3 for patients with anticoagulation. How-
ver, the INR value was not measured at our hospital be-
ause the oral anticoagulation therapy was suspended dur-
ng the period of device implantation. In the long term, the
NR was monitored at the referring hospitals.
Perioperative events were evaluated in all patients. After
mplantation, patients were seen at the outpatient clinic
very 6 months. Median follow-up time was 28.4 (15–38,
aximum 70) months. Two hundred ninety-three patients
ompleted 6 months; 186 patients 1 year; 153 patients 2
ears; 47 patients 3 years; and 13 patients 4 years of follow-
p. LV pacing threshold and pacing impedance values mea-
ured after the implantation were compared with the values
ecorded during 6-, 24-, and 36-month visits. If the patient
xperienced PNS, the PNS threshold was confirmed using
ifferent pulse width values as well. To minimize PNS,
hanging the pacing amplitude, pulse duration, or pacing
onfiguration was attempted. If these maneuvers failed to
erminate intolerable PNS, minimal invasive lead reposi-
ioning was performed.12 A steerable ablation catheter (Cel-
ius, B curve, 36H-37R Biosense Webster, Diamond Bar,
A) was introduced into the right atrium via the right
emoral vein. The ablation catheter was looped around the
trial part of the CS lead and was retracted together with the
S electrode.
If stented CS leads were extracted for any reason, mac-
oscopic analysis was performed in all cases, looking for
njuries on the electrode insulation. When it was possible,
icroscopic measurements were also taken.
Statistical analysis
Statistical analysis was prepared with Prism for Windows
5.00 (GraphPad Software, San Diego, CA, www.graphpad.
com). Since all of the variables had non-Gaussian distribu-
tions, we used nonparametric tests. We used the Wilcoxon
signed rank test for comparisons between two repeated
measures. All statistical analyses were two-tailed and
P .05 was considered statistically significant. Values pre-
sented in the text are medians (interquartile ranges), unless
otherwise stated.
Results
CS side branch stenting was successfully performed in 312
(98.4%) out of 317 patients. In five cases, it was not possible tto introduce the stent into the side branch owing to tortu-
osity of the proximal part or the small diameter of the
vessel. In four cases, the electrode was implanted in the side
branch without stenting, and in one patient we changed to
transseptal endocardial implantation because of intraopera-
tive dislocation. No implantation-related death occurred in
our patient group. Mechanical injury caused by CS stenting
was not experienced. CS dissection with pericardial tam-
ponade was detected in one patient during implantation.
Since contrast dye extravasation was seen in the pericardial
space on the first CS venogram before stent deployment, the
effusion was presumably caused by CS dissection during
positioning of the CS guide. After percutaneous aspiration
from a subxyphoideal puncture, the pericardial effusion did
not recur.
Early lead dislocation with loss of LV capture was de-
tected in two patients (0.6%). Potential causes of the dislo-
cation might be the proximal lead position in a lateral side
branch, underestimation of the diameter of the stent, or the
localization of the stent in a curvature of the vessel. Reop-
eration was performed; in one patient, LV pacing was car-
ried out via the anterolateral branch. PNS was detected in
seven patients (2.2%) during the in-hospital period. Chang-
ing the pacing parameters definitively or transiently solved
the problem. During follow-up, 54 patients died an average
13.4 months after implantation (n  11 during the first 1–3
onths, n 17 during the 3 month to 1 year period, n 16
uring the 1–2 year period, n  10 after 2 years).
Compared with the values measured after the implanta-
ion, the LV pacing threshold did not change significantly
fter 6 months (1.0 [0.6–1.6] vs. 0.8 [0.6–1.3] V; P .052;
igure 3A) or after 24 months of follow-up (0.8 [0.6–1.6]
s. 0.8 [0.6–1.5] V, P  .419; Figure 3C). A clinically
emarkable rise in pacing threshold was observed in two
ases (0.6%). In one patient, the threshold increased after 2
ears (2.2 vs. 5.6 V). In the other case, the lowest threshold
alue was 5.8 V at 0.5 ms during implantation, which
ncreased to 7.2 V at 0.5 ms. In two other cases, the thresh-
ld increased more than 2 V but did not exceed 4 V at 0.5
s. Macroscopic dislocation was not detected on X-ray in
hese four patients. Although a slight decrease of the LV
acing impedance was found at both 6-month (600 [522–
20] vs. 550 [475–639] , P  .0007; Figure 3B) and
24-month visits (608 [535–780] vs. 575 [508–656] , P 
0181; Figure 3D), results of impedance measurements did
ot suggest insulation failure or fracture of the LV electrode
n any cases during follow-up. In patients with 3 (n  47,
igure 3E and 3F) or 4 years (n  13) of follow-up, the
acing threshold remained stable (median 0.9 [0.6–1.65] vs.
.9 [0.6–1.3] V and 0.9 [0.7–2] vs. 1.25 [0.85–2.1] V at 0.5,
espectively), no signs of lead injury were detected (608
522–810] vs. 563 [511–676] and 600 [529–688] vs. 636
553–709] ).
PNS was observed in 18 patients (5.7%). In 11 cases,
eprogramming of the pacing parameters was successful to
erminate PNS. In seven cases (2.2%), repositioning of the
1
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848 Heart Rhythm, Vol 8, No 6, June 2011lead was necessary and the stented LV leads were retracted
with an ablation catheter introduced via the femoral vein in
these patients 1–28 months after implantation. In five cases,
adequate pacing threshold was reached, while in one patient
the threshold increased to 5.0 V at 1 ms. In another patient,
the CS lead dislocated into the right atrium; it was explanted
and a new lead was implanted. PNS was not detected after
repositioning.
Explantation of the stented LV lead was needed in three
patients because of pocket infection (n  2) and endocar-
ditis (n  1) after 3, 49, and 18 months, respectively. Leads
were extracted without any complication while the stent
remained in the CS side branch. Neither signs of insulation
failure nor other macroscopic damage were seen on the
extracted electrodes. Four patients underwent heart trans-plantation (7–27 months after implantation). During the
operation, leads were cut in the superior vena cava, and after
explantation of the heart (Figure 4) the surgeon was able to
extract easily the stented leads from the CS side branch.
Between the stent and the lead, a macroscopically identifi-
able layer of tissue was observed (Figure 5). Macroscopic
injuries could not be seen. Microscopic evaluation was
performed on five CS electrodes (Figure 6). The examina-
tion of the stented area revealed surface damage as a result
of the continuous friction between the stent and the elec-
trode, with a depth of 3–7 m. This depth involved
.7%–4% of the total insulation wall thickness. In one lead,
deeper injury (27% of the insulation thickness) was also
ound, but the sharp edges and long, narrow shape of the
Figure 3 Changes in LV pacing and impedance
values at 6, 24, and 36 months after implantation. LV
pacing threshold did not change at 6, 24, and 36
months of follow-up, while a slight decrease in the LV
pacing impedance values was found without any signs
of injury of the lead insulation. (n  293 at 6 months,
n 153 at 24 months, n 47 at 36 months). Medians
and interquartile ranges are presented. P-values were
calculated with the Wilcoxon signed rank test.
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traction of the lead.
Discussion
Stable LV lead position in the area of latest activation is
important in CRT.13–15 LV lead implantation into the rec-
ommended lateral or posterolateral side branch of the CS is
not feasible due to anatomical and/or technical limitations in
up to one-third of patients.16 An important cause of subop-
timal lead positioning, lead dislodgement, or extracardiac
stimulation is the unstable electrode position in the target
vein.17 The original idea was that CS stenting may decrease
the dislocation rate and improve the success rate of lead
implantation into the recommended side branches by an-
choring the LV lead in an anatomically unstable position.9
CS stent implantation was first used in cases of postopera-
tive lead dislocation. Since complications have not been
observed, stenting also has been performed in cases of
intraoperative dislocation, unstable lead position, or when
Figure 4 Epicardial view of the explanted heart: L: unipolar electrode in
the lateral side branch of the CS; CX: stent in the circumflex artery, which
was implantated when primary PCI was performed in nSTEMI during
follow-up.
Figure 5 Epicardial view of the explanted heart: S: stent in the lateral
ide branch of the CS after explantation of the lead during heart transplan-aation; arrow: place of the explanted CS lead.PNS was found adjacent to the tip of the CS lead. In these
cases, the aim was to prevent potential electrode dislocation.
Stents successfully anchored the CS leads in this patient
group. The consistency of pacing thresholds support the
stability of the stented leads. Macrodislocation was detected
in only two patients. In seven other cases, the cause of lead
repositioning was PNS. PNS is found in 13%–18% of CRT
implantations, and it is one of the main reasons for intra-
operative lead repositioning from an anatomically accept-
able location.18,19 Pacing with high energy during implantation
ay help to avoid subsequent PNS, but despite high-energy
timulation, intraoperative testing in a supine position can-
ot rule out later PNS in other body positions,20 even if the
electrode remains in the same place. In seven cases, a new,
minimally invasive method was performed using an abla-
tion catheter for repositioning of the lead via a femoral
approach. The pacemaker pocket had to be opened for lead
repositioning in only three of our 312 patients (0.9%). This
ratio is much lower than the rate of reoperation reported in
the literature in large multicenter studies.1,21,22
Potential complications due to CS stent implantation
may be the injury of the target vein and/or mechanical
damage of the electrode. Our observations are in line with
prior case reports that describe no complications during
stent implantation into the venous system of the heart23–25
or during stenting to fix the attained electrode position.9–11
Mechanical damage of the lead insulation caused by the
stent may also be a potential problem, especially over a
longer period of time. In our patients, impedance measure-
ments did not suggest insulation failure or fracture of the
LV electrode during follow-up. Optical and mechanical
microscopic analysis of the explanted CS electrodes re-
vealed only mild surface damage in the area of contact with
the stent. The depth of surface injury involved less than 4%
of the total insulation thickness, which suggests that the
stent does not jeopardize the integrity of the lead insula-
tion.26 On explanted hearts, a fibrotic sheath was observed
round the stent enveloping the electrode, which may de-
rease direct friction between the stent and the lead.
There may be significant concern regarding extraction of
Figure 6 CS lead extracted during heart transplantation. Metal micro-
scopic image about the surface covered by the stent. Injury of the lead
insulation was not observed.CS lead fixed with a stent should it become necessary.
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850 Heart Rhythm, Vol 8, No 6, June 2011Although one might believe that it is only possible by
cardiac surgery techniques,27 stented CS leads were ex-
planted with simple traction in three patients (in one case
after 4 years). In addition, four more electrodes were also
easily extracted by traction during heart transplantation.
Moreover, we have managed to alter the CS lead position by
retraction from a distal position with an ablation catheter in
cases of PNS.
Our study is a nonrandomized, uncontrolled single-cen-
ter clinical experience. In this study, mainly unipolar pas-
sive fixation CS leads were implanted. Although our results
seem to be favorable, longer term performance of the
stented LV leads is unknown. Mechanical damage of lead
insulation may occur due to motion between the stent and
the implanted lead, but according to our microscopy mea-
surements, the probability of clinically important injury is
low. CS stent implantation may limit the ability of lead
removal; however, data regarding safe extraction of other
actively fixed CS leads (like StarFix Attain 4195,
Medtronic)28–30 or screw-in pacemaker electrodes in the
CS31 are inconsistent or missing. Notably, we have ex-
tracted stented LV leads without heart surgery in all of our
patients when necessary (n  3; 1%). Moreover, minimally
invasive lead repositioning with an ablation catheter was
also successful (n  7; 2.2%). Although our implantation
success rate was very high, and the dislocation rate of the
stented CS leads was low, a direct comparative multicenter
study would be beneficial to further clarify the advantages
of CS lead stenting.
Conclusion
CS side branch stenting to stabilize CS lead position seems
to be an effective and safe procedure. Using this technique,
the electrode can be fixed in an anatomically unstable but
electrically appropriate position such that the frequency of
lead dislocation, PNS, and reoperations may be lowered. In
our practice, stented CS leads were transvenously explant-
able in all patients when necessary. We endorse CS stent
implantation in cases of postoperative or intraoperative lead
dislocation or if the electrode position is not stable enough
and an alternative side branch is not available at the chosen
location.
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